Metropolitan Life Insurance Company (MetLife)’s Zimmer Biomet ZBH Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,428	Closed	-$1.11M	–	2153
2024 Q1	$1.11M	Sell	8,428 -77	-0.9%	-$9.62K	0.05%	310
2023 Q4	$1.04M	Sell	8,505 -139	-2%	-$15.5K	0.05%	312
2023 Q3	$970K	Sell	8,644 -444	-5%	-$56.4K	0.05%	301
2023 Q2	$1.32M	Sell	9,088 -297	-3%	-$40.4K	0.06%	267
2023 Q1	$1.21M	Sell	9,385 -2,752	-23%	-$346K	0.06%	284
2022 Q4	$1.55M	Sell	12,137 -355	-3%	-$41.2K	0.07%	272
2022 Q3	$1.31M	Sell	12,492 -130	-1%	-$14.3K	0.06%	291
2022 Q2	$1.33M	Sell	12,622 -270	-2%	-$32K	0.06%	303
2022 Q1	$1.65M	Sell	12,892 -11,698	-48%	-$1.41M	0.06%	303
2021 Q4	$3.03M	Sell	24,590 -706	-3%	-$92.4K	0.04%	357
2021 Q3	$3.59M	Sell	25,296 -824	-3%	-$121K	0.05%	291
2021 Q2	$4.08M	Sell	26,120 -311	-1%	-$50.4K	0.06%	271
2021 Q1	$4.11M	Sell	26,431 -1,237	-4%	-$192K	0.06%	255
2020 Q4	$4.14M	Sell	27,668 -1,447	-5%	-$204K	0.06%	247
2020 Q3	$3.85M	Sell	29,115 -1,255	-4%	-$164K	0.07%	234
2020 Q2	$3.52M	Sell	30,370 -1,668	-5%	-$192K	0.06%	251
2020 Q1	$3.14M	Sell	32,038 -123	-0.4%	-$16.1K	0.06%	249
2019 Q4	$4.67M	Buy	32,161 +727	+2%	+$100K	0.07%	224
2019 Q3	$4.19M	Buy	31,434 +199	+0.6%	+$25.7K	0.07%	240
2019 Q2	$3.57M	Buy	31,235 +2,524	+9%	+$296K	0.06%	277
2019 Q1	$3.56M	Sell	28,711 -1,224	-4%	-$139K	0.06%	251
2018 Q4	$3.01M	Sell	29,935 -303	-1%	-$34.1K	0.06%	265
2018 Q3	$3.86M	Sell	30,238 -1,118	-4%	-$133K	0.07%	247
2018 Q2	$3.39M	Sell	31,356 -881	-3%	-$95.9K	0.06%	283
2018 Q1	$3.41M	Buy	32,237 +281	+0.9%	+$32.6K	0.05%	284
2017 Q4	$3.74M	Sell	31,956 -66,508	-68%	-$7.52M	0.05%	277
2017 Q3	$11.2M	Sell	98,464 -1,325	-1%	-$153K	0.07%	248
2017 Q2	$12.4M	Sell	99,789 -6,180	-6%	-$733K	0.09%	215
2017 Q1	$12.6M	Sell	105,969 -1,157	-1%	-$131K	0.09%	223
2016 Q4	$10.7M	Sell	107,126 -2,891	-3%	-$310K	0.08%	243
2016 Q3	$13.9M	Sell	110,017 -685	-0.6%	-$84.6K	0.1%	193
2016 Q2	$12.9M	Buy	110,702 +13,811	+14%	+$1.56M	0.1%	203
2016 Q1	$10M	Buy	96,891 +2,275	+2%	+$220K	0.08%	243
2015 Q4	$9.42M	Sell	94,616 -1,063	-1%	-$104K	0.07%	263
2015 Q3	$8.72M	Sell	95,679 -1,523	-2%	-$153K	0.06%	289
2015 Q2	$10.3M	Buy	97,202 +105	+0.1%	+$11.6K	0.07%	259
2015 Q1	$11.1M	Sell	97,097 -985	-1%	-$112K	0.08%	245
2014 Q4	$10.8M	Sell	98,082 -475	-0.5%	-$50.1K	0.07%	261
2014 Q3	$9.62M	Sell	98,557 -849	-0.9%	-$83.5K	0.07%	274
2014 Q2	$10M	Sell	99,406 -5,611	-5%	-$547K	0.07%	277
2014 Q1	$9.64M	Sell	105,017 -2,677	-2%	-$247K	0.07%	291
2013 Q4	$9.74M	Sell	107,694 -1,200	-1%	-$104K	0.07%	293
2013 Q3	$8.68M	Buy	108,894 +130	+0.1%	+$10.2K	0.07%	306
2013 Q2	$7.91M	Buy	+108,764	New	+$8.13M	0.06%	318

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ZBH Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 8,428 shares — an estimated $1.11M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ZBH in Q2 2013 and held it in 44 quarters. The position peaked at $13.9M in Q3 2016. 1,007 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 8,428 Zimmer Biomet shares in Q2 2024, an estimated $1.11M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Zimmer Biomet in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Zimmer Biomet position peaked at $13.9M in Q3 2016.
1,007 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.